Abstract
Abstract
Pasteurella multocida is an important bacterial pathogen that can cause diseases in both animals and humans. Its elevated morbidity and mortality rates in animals result in substantial economic repercussions within the livestock industry. The prevention of diseases caused by P. multocida through immunization is impeded by the absence of a safe and effective vaccine. Outer membrane vesicles (OMVs) secreted from the outer membrane of Gram-negative bacteria are spherical vesicular structures that encompass an array of periplasmic components in conjunction with a diverse assortment of lipids and proteins. These vesicles can induce antibacterial immune responses within the host. P. multocida has been shown to produce OMVs. Nonetheless, the precise characteristics and immunomodulatory functions of P. multocida OMVs have not been fully elucidated. In this study, OMVs were isolated from P. multocida using an ultrafiltration concentration technique, and their morphology, protein constitution, and immunomodulatory properties in RAW264.7 cells were studied. Transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA) revealed that the OMVs exhibited typical spherical and bilayered lipid vesicular architecture, exhibiting an average diameter of approximately 147.5 nm. The yield of OMVs was 2.6 × 1011 particles/mL. Proteomic analysis revealed a high abundance of membrane-associated proteins within P. multocida OMVs, with the capability to instigate the host’s immune response. Furthermore, OMVs stimulated the proliferation and cellular uptake of macrophages and triggered the secretion of cytokines, such as TNF-ɑ, IL-1β, IL-6, IL-10, and TGF-β1. Consequently, our results indicated that OMVs from P. multocida could directly interact with macrophages and regulate their immune function in vitro. These results supported the prospective applicability of P. multocida OMVs as a platform in the context of vaccine development.
Key points
• Preparation and characterization of P. multocida OMVs.
• P. multocida OMVs possess a range of antigens and lipoproteins associated with the activation of the immune system.
• P. multocida OMVs can activate the proliferation, internalization, and cytokine secretion of macrophages in vitro.
Funder
China Agriculture Research System of MOF and MARA
National Natural Science Foundation of China
Key Research and Development Program of Zhejiang Province
Pioneer and Leading Goose R&D Program of Zhejiang
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Acevedo R, Fernández S, Zayas C, Acosta A, Sarmiento ME, Ferro VA, Rosenqvist E, Campa C, Cardoso D, Garcia L, Perez JL (2014) Bacterial outer membrane vesicles and vaccine applications. Front Immunol 5:121. https://doi.org/10.3389/fimmu.2014.00121
2. Agrawal A, Varshney R, Gattani A, Kirthika P, Khan MH, Singh R, Kodape S, Patel SK, Singh P (2020) Gold nanoparticle based immunochromatographic biosensor for rapid diagnosis of Mycobacterium avium subspecies paratuberculosis infection using recombinant protein. J Microbiol Methods 177:106024. https://doi.org/10.1016/j.mimet.2020.106024
3. Boyce JD, Adler B (2000) The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2). Infect Immun 68(6):3463–3468
4. Boyce JD, Adler B (2006) How does Pasteurella multocida respond to the host environment? Curr Opin Microbiol 9(1):117–122
5. Brown GD (2006) Macrophage Receptors and Innate Immunity: Insights from Dectin‐1. In: Innate Immunity to Pulmonary Infection: Novartis Foundation Symposium. Chichester, UK, John Wiley & Sons, Ltd., p 279
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献